The editors of The Lancet yesterday issued a statement acknowledging the criticism of a recent study that concluded that the antimalaria drugs hydroxychloroquine and chloroquine did not benefit COVID-19 patients and were associated with higher risk of death and serious heart rhythm complications.The statement comes in response to a letter signed by more than 100 scientists and clinicians worldwide that raised questions about the data behind the large observational study.The Lancet said in its statement that important scientific questions had been raised about the data reported in the paper, and that an independent audit of the data commissioned by the authors is ongoing.The study, published in The Lancet on May 22, compared outcomes in
Read more on cidrap.umn.edu